Related Experiment Video
Updated: Apr 1, 2026

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
Published on: October 30, 2012
Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans
H Wang1,2, B Liu1,2, A Q O Al-Aidaroos3
1Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Abstract:
Despite abundant data supporting c-Src as a metastasis-promoting oncogene, activating mutations of c-Src are rare. This suggests that trans-interacting proteins may have a critical role in regulating c-Src activation. Here, we first report the discovery of Src homology 3 (SH3) domain-binding glutamic acid-rich-like protein (SH3BGRL), a novel c-Src activator in mice. Ectopic expression of murine SH3BGRL (mSH3BGRL) strongly promoted both tumor cell invasion and lung metastasis. Molecularly, mSH3BGRL specifically bound the inactive form of c-Src phosphorylated at Tyr527, promoting Tyr416 phosphorylation of c-Src and subsequent FAK-mediated activation of ERK and AKT signaling pathways. Targeting endogenous c-Src alone was sufficient to abolish mSH3BGRL-induced cancer metastasis in vivo. Unexpectedly, human SH3BGRL (hSH3BGRL) in turn suppressed tumorigenesis and metastasis in nature. We attempted site-specific reversion of hSH3BGRL amino-acid sequence to mSH3BGRL and found V108A substitution sufficient to restore SH3BGRL function as a c-Src activator and metastasis promoter. Notably, the somatic mutation R76C of hSH3BGRL can similarly act as hSH3BGRL-V108A and mSH3BGRL in tumorigenesis and metastasis. Our results uncover an evolutionarily controversial role of SH3BGRL in driving tumor metastasis through c-Src activation, and suggests that hSH3BGRL mutation status could be relevant to cancer diagnosis and therapy.
Insights
A novel protein, Src homology 3 (SH3) domain-binding glutamic acid-rich-like protein (SH3BGRL), activates c-Src to promote cancer metastasis in mice. However, human SH3BGRL suppresses metastasis, with specific mutations restoring its oncogenic function.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- c-Src is a known oncogene promoting metastasis, but activating mutations are rare.
- Trans-acting proteins are implicated in regulating c-Src activation.
- The role of SH3BGRL in cancer has not been previously defined.
Purpose of the Study:
- To identify novel regulators of c-Src activation.
- To investigate the role of SH3BGRL in cancer metastasis.
- To explore the differential functions of murine and human SH3BGRL.
Main Methods:
- Discovery and characterization of murine SH3BGRL (mSH3BGRL).
- Assays for tumor cell invasion and lung metastasis.
- Molecular analysis of c-Src phosphorylation and downstream signaling pathways (FAK, ERK, AKT).
- Site-specific mutation analysis of human SH3BGRL (hSH3BGRL).
Main Results:
- Ectopic mSH3BGRL expression promoted tumor cell invasion and lung metastasis.
- mSH3BGRL binds inactive c-Src, promoting its activation and downstream signaling.
- Targeting c-Src abolished mSH3BGRL-induced metastasis.
- hSH3BGRL suppressed tumorigenesis and metastasis.
- A V108A substitution in hSH3BGRL restored its oncogenic function.
- The somatic mutation R76C in hSH3BGRL also promoted tumorigenesis and metastasis.
Conclusions:
- SH3BGRL has an evolutionarily divergent role in cancer metastasis via c-Src activation.
- Murine SH3BGRL acts as a c-Src activator promoting metastasis.
- Human SH3BGRL generally suppresses metastasis, but specific mutations confer oncogenic activity.
- SH3BGRL mutation status may be relevant for cancer diagnosis and therapy.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Abnormal Proliferation
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Negative Regulator Molecules

